Fever in hospitalized HIV-infected patients in Western French Guiana: First think histoplasmosis

International Journal of STD and AIDS

Volumn 25, Issue 9, 2014, Pages 656-661

  Vantilcke, Vincent ^a   Boukhari, Rachida ^a   Jolivet, Anne ^a   Vautrin, Cyrille ^a   Misslin, Caroline ^a   Adenis, Antoine ^b,c   Nacher, Mathieu ^b,c  

^a Centre Hospitalier de l'Ouest Guyanais   (French Guiana)

^b CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^c UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

Author keywords

AIDS; fever; French Guiana; Histoplasma capsulatum; histoplasmosis; HIV; opportunistic infection; primary prophylaxis

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; CD4 ANTIGEN; CEFTRIAXONE; CLAVULANIC ACID; ITRACONAZOLE; QUINOLONE DERIVATIVE; AMPHOTERICIN B;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE DURATION; FEMALE; FEVER; FRENCH GUIANA; HISTOPLASMOSIS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOCOMPROMISED PATIENT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADOLESCENT; AGE DISTRIBUTION; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPLICATION; EPIDEMIOLOGY; HISTOPLASMA; ISOLATION AND PURIFICATION; MIDDLE AGED; MIXED INFECTION; MORTALITY; PREVALENCE; SEX RATIO; STATISTICS AND NUMERICAL DATA; VIROLOGY; WEIGHT REDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; FEVER; FRENCH GUIANA; HISTOPLASMA; HISTOPLASMOSIS; HIV INFECTIONS; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; WEIGHT LOSS; YOUNG ADULT;

EID: 84905651346     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462413516299     Document Type: Article

References (20)

1. Nacher M,Vantilcke V,Parriault MCet al.What is driving the HIV epidemic in French Guiana?.Int J STD AIDS. 2010;21:359-361.
2. Gaubert Maréchal Emilie JA,Van melle Astrid,Parriault Marie Claireet al.Knowledge, attitudes, beliefs, practices on HIV/AIDS among boatmen on the Maroni river: a neglected bridging group?.J AIDS Clin Res. 2012;3:181.
3. Couppie P,Sobesky M,Aznar Cet al.Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors.Clin Infect Dis. 2004;38:134-138.
4. Hanf M,Adenis A,Couppie Pet al.HIV-associated histoplasmosis in French Guiana: recent infection or reactivation?.AIDS. 2010;24:1777-1778.
5. De Pauw B,Walsh TJ,Donnelly JPet al.Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.Clin Infect Dis. 2008;46:1813-1821.
6. Simon S,Veron V,Boukhari Ret al.Detection of Histoplasma capsulatum DNA in human samples by real-time polymerase chain reaction.Diagn Microbiol Infect Dis. 2010;66:268-273.
7. Nacher M,El Guedj M,Vaz Tet al.Risk factors for late HIV diagnosis in French Guiana.AIDS. 2005;19:727-729.
8. Mugavero MJ,Castellano C,Edelman Det al.Late diagnosis of HIV infection: the role of age and sex.Am J Med. 2007;120:370-373.
9. Delpierre C,Cuzin L,Lauwers-Cances Vet al.High-risk groups for late diagnosis of HIV infection: a need for rethinking testing policy in the general population.AIDS Patient Care STDS. 2006;20:838-847.
10. Pontes LB,Leitao Tdo M,Lima GGet al.[Clinical and evolutionary characteristics of 134 patients with disseminated histoplasmosis associated with AIDS in the State of Ceara].Rev Soc Bras Med Trop. 2010;43:27-31.
11. Couppie P,Aznar C,Carme Bet al.American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis.Curr Opin Infect Dis. 2006;19:443-449.
12. Huber F,Nacher M,Aznar Cet al.AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana.AIDS. 2008;22:1047-1053.
13. Wheat LJ,Freifeld AG,Kleiman MBet al.Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.Clin Infect Dis. 2007;45:807-825.
14. Nacher M,Aznar C,Blanchet Det al.AIDS-related disseminated histoplasmosis in the greater Caribbean: how frequent is it?.AIDS. 2006;20:951-952.
15. Van der Schee AC,Dinkla BA,Festen JJ.Gonarthritis as only manifestation of chronic disseminated histoplasmosis.Clin Rheumatol. 1990;9:92-94.
16. Peters EJ,Kauffmann RH,Blok P.Fever and high lactate dehydrogenase in HIV-positive patients from the Antilles and Surinam: histoplasmosis?.Neth J Med. 2006;64:302-306.
17. Joore JC,Marcelis JH,Sie-Go DMet al.[Histoplasma capsulatum infection, a manifestation of AIDS unusual for The Netherlands].Ned Tijdschr Geneeskd. 1990;134:1908-1910.
18. Ribeiro LC,Hahn RC,Favalessa OCet al.[Systemic mycosis: factors associated with death among patients infected with the human immunodeficiency virus, Cuiaba, State of Mato Grosso, Brazil, 2005-2008].Rev Soc Bras Med Trop. 2009;42:698-705.
19. Nacher M,Adenis A,Basurka Cet al.Primary prophylaxis of disseminated histoplasmosis in HIV patients in French Guiana: a cost effectiveness study.Am J Trop Med Hyg. 2013;89:1195-1198.
20. McKinsey DS.Histoplasmosis in AIDS: advances in management.AIDS Patient Care STDS. 1998;12:775-781.